Osimertinib (Standard)
Osimertinib (Standard) is the analytical standard of Osimertinib. This product is intended for research and analytical applications. Osimertinib (AZD9291) is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M, respectively. Osimertinib overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer[1].
Product Specifications
CAS Number
1421373-65-0
Product Name Alternative
AZD-9291 (Standard) ; Mereletinib (Standard)
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
EGFR; Reference Standards
Type
Reference Standards
Related Pathways
JAK/STAT Signaling; Others; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/osimertinib-standard.html
Purity
99.69
Smiles
C=CC(NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OC)C=C1N(CCN(C)C)C)=O
Molecular Formula
C28H33N7O2
Molecular Weight
499.61
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C, sealed storage, away from light and moisture
Scientific Category
Reference Standards
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker) (PMEL/2037), CF647 conjugate, 0.1mg/mL
MHC II (HLA-DRA) (19-26.1), Biotin conjugate, 0.1mg/mL
![PD1 (PDCD1) Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI9G6]](https://cdn.genprice.uk/products/937/6868c3d8994c49e6dc4008a5/imageurl/ta808034bm.webp)